Knight Therapeutics Inc. (GUD) EPS Estimated At $0.02; Trustmark (TRMK) Has 1.06 Sentiment Stocks Beat
Analysts expect Knight Therapeutics Inc. (TSE:GUD) to report $0.02 EPS on August, 8.They anticipate $0.01 EPS change or 33.33% from last quarter’s $0.03 …